Tiziana Life Sciences – AIM Delisting and Admission to the Standard Listing Segment of Main Market January 20, 2021 – Posted in: Tiziana Life Sciences (TILS)

20th January, 2021 Tiziana Life Sciences plc (“Tiziana” or the “Company”) AIM Delisting and Admission to the Standard Listing Segment of Main Market Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today provided a further update with respect to the cancellation of admission of its Ordinary Shares to trading on AIM and admission to listing of its ordinary…

Continue reading